Ephedra Safety Risk Evidence Sufficient For Market Ban – Rep. Waxman
This article was originally published in The Tan Sheet
Executive Summary
There is currently enough evidence of risk to remove ephedra from the market, Rep. Henry Waxman (D-Calif.) maintained at the Food & Drug Law Institute's Annual Educational Conference in Washington, D.C. April 1